Starting in 2026, Medicare will launch two pilot programs, GLOBE and GUARD, aimed at reducing prescription drug costs for ...
Dahlak Brathwaite’s “Try/Step/Trip,” part of the Under the Radar festival, uses the language of step to express the ...
Drugmakers to cut prices on most drugs sold to the Medicaid program U.S. patients pay the most for prescription medicines Dec 19 (Reuters) - U.S. President Donald Trump and nine major pharmaceutical ...
President Trump announced nine more pharmaceutical companies have agreed to implement "most favored nation pricing". Trump signs executive order to reclassify marijuana Bucking tradition: Why some New ...
WASHINGTON, Dec 18 (Reuters) - (This December 18 story has been corrected to say 2026, not 2025, in the headline) Sign up here. Medicare negotiated prices kick in next month for 10 drugs, a first for ...
LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat ...
Fluorine is critical for biomedicine. This element can help drug compounds be more potent and last longer in the body, and its radioactive isotope, fluorine-18, powers medical imaging techniques such ...
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced that ...
This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.
A new class of drugs is saving the lives of children who once had no hope. These high-tech medicines can replace defective genes. But there's a catch. Many cost millions of dollars for a single dose.
Medetomidine, a veterinary sedative, mixed into fentanyl has sent thousands to hospitals, not only for overdose but for life-threatening withdrawal. It is spreading to other cities. Joseph is newly in ...
Forbes contributors publish independent expert analyses and insights. I write about economic policy for the 21st century. In 2019, I was involved in a crypto project that aimed to provide a usable ...